ATW SPAC Management’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.24K Hold
60,540
﹤0.01% 150
2025
Q2
$981 Hold
60,540
﹤0.01% 121
2025
Q1
$2.42K Hold
60,540
﹤0.01% 109
2024
Q4
$5.02K Hold
60,540
0.01% 107
2024
Q3
$2.35K Buy
+60,540
New +$2.28K ﹤0.01% 144
2023
Q4
Sell
-60,540
Closed -$6.02K 179
2023
Q3
$2.48K Hold
60,540
﹤0.01% 175
2023
Q2
$11.4K Hold
60,540
0.01% 152
2023
Q1
$19.4K Sell
60,540
-39,460
-39% -$9.26K 0.01% 125
2022
Q4
$4.95K Hold
100,000
﹤0.01% 187
2022
Q3
$12K Hold
100,000
﹤0.01% 268
2022
Q2
$16K Hold
100,000
﹤0.01% 278
2022
Q1
$20 Buy
+100,000
New +$23.8K ﹤0.01% 265

Other funds holding CDIOW

ATW SPAC Management's CDIOW Position: Q3 2025 in Review

ATW SPAC Management held its Cardio Diagnostics Holdings Inc Warrant (CDIOW) position steady in Q3 2025 at 60,540 shares worth $1.24K. The position accounts for ﹤0.01% of the portfolio, ranked #150.

ATW SPAC Management first reported a position in CDIOW in Q1 2022 and has held it in 12 quarters since. The position peaked at $19.4K in Q1 2023. 10 funds tracked by Wall St. Rank hold CDIOW as of Q3 2025.

  • ATW SPAC Management held 60,540 shares of Cardio Diagnostics Holdings Inc Warrant worth $1.24K as of Q3 2025.
  • ATW SPAC Management left its Cardio Diagnostics Holdings Inc Warrant share count unchanged in Q3 2025.
  • Cardio Diagnostics Holdings Inc Warrant made up ﹤0.01% of ATW SPAC Management's portfolio in Q3 2025, its #150 holding.
  • ATW SPAC Management first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q1 2022 and has held it in 12 quarters since.
  • ATW SPAC Management's Cardio Diagnostics Holdings Inc Warrant position peaked at $19.4K in Q1 2023.
  • 10 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q3 2025.

Based on ATW SPAC Management's 13F filing for Q3 2025, filed 12 Nov 2025.